Patient Advocacy & Engagement Roundtable

The T2B Patient Advocacy & Engagement Roundtable unites biopharma communicators who are passionate about engaging patients as essential stakeholders. This roundtable focuses on helping communicators build authentic connections with patient communities and advocacy organizations, highlighting how meaningful engagement is not only the “right thing to do,” but also a critical driver of business success.

Roundtable objectives

  • Create an environment where like-minded communicators exchange ideas, share experiences, and define best practices for patient-first storytelling.
  • Develop frameworks for working with internal teams, such as medical affairs and R&D, to align patient advocacy efforts with overarching corporate goals.
  • Explore ways to foster trust and credibility with patient communities through transparent, culturally sensitive, and compliant communication strategies.
  • Provide tools to measure and articulate the impact of patient advocacy, demonstrating its value to internal stakeholders and clients, reinforcing its role as a business imperative.

Upcoming & Recent Patient Advocacy & Engagement Roundtables

Upcoming

More details on our next Roundtable coming soon!

Recent Patient Advocacy & Engagement Roundtable Resources

Chair
Mike Walsh

Mike Walsh

Founder & CEO

Patient Advocacy Strategies

Roundtable members

Erica Bersin

Erica Bersin

President

ERO Health Communications

Alejandra Cerros

Alejandra Cerros

Corporate Communications & Marketing

Dennig Marketing Group

Jeff Sears

Jeff Sears

Global Head, Strategy and Operations, Communications and Investor Relations

Astellas Pharma

Julissa Viana

Julissa Viana

Vice President, Corporate Communications, Investor Relations & Patient Advocacy

Verastem Oncology

Lauren Walrath

Lauren Walrath

Head of US Communications and Media

Organon

Chief of Staff / PM
Heather Goldman

Heather Goldman

Associate Director, Executive & Business Administration

Neumora

“We’re thrilled to launch the Patient Advocacy & Engagement Roundtable as a workstream of T2B to explore optimal approaches that amplify the patient voice throughout the life sciences industry and harness best practices for those seeking to integrate patient engagement work into their biopharma efforts.”

Mike Walsh

Founder & CEO, Patient Advocacy Strategies

Interested in joining this roundtable?

Why join

  • Harness your professional experience and passion for patient engagement within the biopharma space by driving the exchange of insights and meaningful storytelling that demonstrates the value of proactive patient partnerships on life science innovation at all stages of development.
  • Crystalize patient engagement best practices across the life sciences industry by demonstrating what good looks like through T2B education and programming.
  • Advance your role as an SME thought leader as it relates to professional patient engagement and forge meaningful connections within T2B’s community of 1K+ communicators.

Eligibility requirements

Applicants must have:

  • A passion for integrating patients into life science innovation.
  • The ability to volunteer 3-5 hours/month to co-create quarterly PA&E RT events and monthly resources for the broader T2B community.
  • Self-driven ambition to coordinate, collaborate, ideate, and participate in quarterly PA&E Roundtable team meetings and contribute ideas and feedback.
  • An active T2B Pro membership.

Apply for a spot on the Patient Advocacy & Engagement Roundtable

Applications are closed and will reopen in May 2026. Each member term is for one calendar year.